Immunofluorescence staining
OCT-embedded brain sections were cut. The sections were blocked with protein block (Dako, Glostrup, Denmark) for 10 min. Primary antibody (Ab), anti CCR4 (R&D Systems, Minneapolis, MA, USA); diluted 1:500, was incubated for 1 h at room temperature (RT), followed by fluorescently conjugated secondary Ab for 30 min at RT. Coverslips were mounted using Vectamount with DAPI (Vector Laboratories). The images were viewed with a × 63/1.4 oil objective, using a Leica SP5 microscope and Leica SP5 software (LAS-AF, Leica, Germany) or a confocal microscope (LSM 510, Carl Zeiss, Germany) and LSM image browser.
RNA preparation and reverse transcription polymerase chain reaction
Total RNA was extracted using the EZ-RNA Total RNA Isolation Kit (Biological Industries, Kibbutz BeitHaemek, Israel), followed by cDNA synthesis with M-MLV Reverse Transcriptase (Ambion Inc., Foster City, CA, USA). The detection of human melanoma cells was performed as we previously described (6).
Real-time PCR reactions were run in triplicate using primers specific for human β2M, mouse β2M, human CCL22 and human CCL17 cDNAs. qRT-PCR was conducted with iTaq Universal SYBR Green Supermix (BioRad, CA, USA).
Isolation and characterization of CCR4+ sorted melanoma cells
Brain metastatic melanoma variant cells, YDFR. CB3, were incubated with an anti-CCR4 mAb (mouse IgG1) or a control mAb at 4°C for 30 min. After washing, cells were stained with FITC-conjugated anti-mouse IgG (Dako). Then, cells were analysed on a FACSAria (Becton Dickinson, San Jose, CA) and were sorted for isolation of CCR4 positive melanoma cell population. CCR4 positive population of melanoma cells (CCR4-SORT) were expanded as polyclonal lines for 9-14 days.
